(HealthDay News) -- Sanofi-Aventis's Apidra (insulin glulisine) Solostar injection pen has been approved to treat diabetes, the company said Thursday in a news release.
The disposable pen with rapid-acting insulin was approved for adults with type 2 diabetes and for children four years and older with type 1 diabetes.
The device requires lower injection force than competing products, the drug maker said.
More information
The FDA has additional information about Apidra, a drug first approved in 2004.
Subscribe to:
Post Comments (Atom)
Dr. Group's Secret to Health Kit$39.94  Dr. Group's Secret to Health Kit offers simple at-home solutions for cleansing internally and externally thereby reducing toxins, restoring the body's natural healing process, and helping you achieve true health and happiness. |
No comments:
Post a Comment